Multimodal prehabilitation in patients with non-small cell lung cancer undergoing anatomical resection: protocol of a non-randomised feasibility study
- PMID: 37468983
- PMCID: PMC10355002
- DOI: 10.1186/s13741-023-00326-y
Multimodal prehabilitation in patients with non-small cell lung cancer undergoing anatomical resection: protocol of a non-randomised feasibility study
Abstract
Background: The preoperative period can be used to enhance a patient's functional capacity with multimodal prehabilitation and consequently improve and fasten postoperative recovery. Especially, non-small cell lung cancer (NSCLC) surgical patients may benefit from this intervention, since the affected and resected organ is an essential part of the cardiorespiratory fitness. Drafting a prehabilitation programme is challenging, since many disciplines are involved, and time between diagnosis of NSCLC and surgery is limited. We designed a multimodal prehabilitation programme prior to NSCLC surgery and aimed to conduct a study to assess feasibility and indicative evidence of efficacy of this programme. Publication of this protocol may help other healthcare facilities to implement such a programme.
Methods: The multimodal prehabilitation programme consists of an exercise programme, nutritional support, psychological support, smoking cessation, patient empowerment and respiratory optimisation. In two Dutch teaching hospitals, 40 adult patients with proven or suspected NSCLC will be included. In a non-randomised fashion, 20 patients follow the multimodal prehabilitation programme, and 20 will be assessed in the control group, according to patient preference. Assessments will take place at four time points: baseline, the week before surgery, 6 weeks postoperatively and 3 months postoperatively. Feasibility and indicative evidence of efficacy of the prehabilitation programme will be assessed as primary outcomes.
Discussion: Since the time between diagnosis of NSCLC and surgery is limited, it is a challenge to implement a prehabilitation programme. This study will assess whether this is feasible, and evidence of efficacy can be found. The non-randomised fashion of the study might result in a selection and confounding bias. However, the control group may help putting the results of the prehabilitation group in perspective. By publishing this protocol, we aim to facilitate others to evaluate and implement a multimodal prehabilitation programme for surgical NSCLC patients.
Trial registration: The current study is registered as NL8080 in the Netherlands Trial Register on the 10th of October 2019, https://www.trialregister.nl/trial/8080 . Secondary identifiers: CCMO (Central Committee on Research Involving Human Subjects) number NL70578.015.19, reference number of the Medical Ethical Review Committee of Máxima MC W19.045.
Keywords: Anatomical resection; Enhanced recovery after thoracic surgery; Feasibility; Functional capacity; Lung surgery; Non-small cell lung cancer; Physical conditioning; Postoperative outcome; Prehabilitation; Preoperative intervention.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study.J Thorac Dis. 2024 May 31;16(5):2776-2789. doi: 10.21037/jtd-23-1929. Epub 2024 May 10. J Thorac Dis. 2024. PMID: 38883662 Free PMC article.
-
EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.BMJ Open. 2023 Mar 7;13(3):e071304. doi: 10.1136/bmjopen-2022-071304. BMJ Open. 2023. PMID: 36882246 Free PMC article.
-
Is personalised prehabilitation feasible to implement for patients undergoing oncological treatment for lung cancer at a London teaching hospital? Protocol of a feasibility trial.BMJ Open. 2023 Jul 17;13(7):e072367. doi: 10.1136/bmjopen-2023-072367. BMJ Open. 2023. PMID: 37460263 Free PMC article.
-
Prehabilitation in thoracic surgery.J Thorac Dis. 2018 Aug;10(Suppl 22):S2593-S2600. doi: 10.21037/jtd.2018.08.18. J Thorac Dis. 2018. PMID: 30345096 Free PMC article. Review.
-
A Narrative Review About Prehabilitation in Surgery: Current Situation and Future Perspectives.Cir Esp (Engl Ed). 2020 Apr;98(4):178-186. doi: 10.1016/j.ciresp.2019.11.005. Epub 2020 Jan 25. Cir Esp (Engl Ed). 2020. PMID: 31987464 English, Spanish.
Cited by
-
Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study.J Thorac Dis. 2024 May 31;16(5):2776-2789. doi: 10.21037/jtd-23-1929. Epub 2024 May 10. J Thorac Dis. 2024. PMID: 38883662 Free PMC article.
References
-
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365. - DOI - PubMed
-
- Achttien RJ, Staal JB, Merry A, et al. KNGF-richtlijn Hartrevalidatie. 2011.
-
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, Brunelli A, Cerfolio RJ, Gonzalez M, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS) Eur J Cardiothorac Surg. 2019;55(1):91–115. doi: 10.1093/ejcts/ezy301. - DOI - PubMed
LinkOut - more resources
Full Text Sources